CytomX Therapeutics CEO Sean McCarthy's 2023 pay slips 13% to $2.6M
CytomX Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 4, 2024
CytomX Therapeutics reported fiscal year 2023 executive compensation information on April 4, 2024.
In 2023, three executives at CytomX Therapeutics received on average a compensation package of $1.6M, a 5% decrease compared to previous year.
Average pay of disclosed executives at CytomX Therapeutics
Sean A. McCarthy, Chief Executive Officer, received $2.6M in total, which decreased by 13% compared to 2022. 40% of McCarthy's compensation, or $1M, was in stock awards. McCarthy also received $372K in non-equity incentive plan, $533K in option awards, $652K in salary, as well as $5K in other compensation.
Marcia P. Belvin, Chief Scientific Officer, received a compensation package of $1.2M. 38% of the compensation package, or $460K, was in salary.
Jeff Landau, Senior Vice President and Chief Business Officer, earned $1M in 2023, a 1% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 4, 2024.